An official website of the United States government
NIH Guide: Weekly Index for March 18, 2022
Weekly NIH Funding Opportunities and Notices
March 18, 2022
Policy Notices
-
AHRQ Announces Interest in Primary Care Research
(NOT-HS-22-011)Agency for Healthcare Research and Quality
General Notices
-
Notice of NCCIH Technical Assistance Webinar for RFA-AT-22-001, "NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)
(NOT-AT-22-016)National Center for Complementary and Integrative Health
-
NIDA Challenge "CODE (Cause of Death Elucidated) in Drug Overdose: Rapid and portable cause of death detection technologies to improve drug overdose-related mortality counts"
(NOT-DA-22-054)National Institute on Drug Abuse
-
Findings of Research Misconduct
(NOT-OD-22-095)Office of the Director, NIH
-
Findings of Research Misconduct
(NOT-OD-22-096)Office of the Director, NIH
-
Findings of Research Misconduct
(NOT-OD-22-097)Office of the Director, NIH
-
Findings of Research Misconduct
(NOT-OD-22-098)Office of the Director, NIH
-
Request for Information (RFI): Inviting comments to inform the National Institutes of Health (NIH) on the intersection of the SARS-CoV-2/COVID-19 pandemic and the health of women
(NOT-OD-22-092)Office of Research on Women's Health
-
Request for Information (RFI): Challenges and Opportunities in Elucidating the Human Virome
(NOT-RM-22-010)Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
-
Notice of Cancellation of RFA-DK-22-005, Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
(NOT-DK-22-019)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to update Eligibility Information under RFA-FD-22-010; "Revision Applications - Development and Maintenance of the Animal Feed Regulatory Program Standards Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18)"
(NOT-FD-22-009)Food and Drug Administration
-
Notice of Correction to Eligibility and Application Types in RFA-HL-23-006, "
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
(NOT-HL-22-013)National Heart, Lung, and Blood Institute
-
Notice of Change to PAR-21-357 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
(NOT-NS-22-075)National Institute of Neurological Disorders and Stroke
-
Notice to Extend Expiration Date for PAR-20-128: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
(NOT-OD-22-085)Office of the Director, NIH
-
Notice to Extend Expiration Date for PAR-20-129: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
(NOT-OD-22-086)Office of the Director, NIH
-
Notice to Extend Expiration Date for PAR-20-130: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
(NOT-OD-22-087)Office of the Director, NIH
-
Notice of Change to RFA-OD-22-004, Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
(NOT-OD-22-094)Office of Disease Prevention
-
Notice of Change to Correct Eligibility Information under RFA-RM-22-008; "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)"
(NOT-RM-22-011)Office of Strategic Coordination (Common Fund)
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for An Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
(NOT-HG-22-012)National Human Genome Research Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data.
(NOT-CA-22-056)National Cancer InstituteNational Institute of Environmental Health Sciences
-
Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
(NOT-TR-22-023)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Funding Opportunities
-
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
(PAR-22-133)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
NIAID Research Education Program (R25 Clinical Trial Not Allowed)
(PAR-22-134)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
(PAR-22-137)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute of Environmental Health SciencesOffice of Research on Women's HealthApplication Receipt Date(s): January 7, 2025
-
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
(PAR-22-138)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute of Environmental Health SciencesOffice of Research on Women's HealthApplication Receipt Date(s): January 7, 2025
-
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
(PAR-22-139)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
(PAR-22-140)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
(PAR-22-141)National Eye InstituteApplication Receipt Date(s): January 1, 2025
-
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed)
(RFA-DA-23-004)National Institute on Drug AbuseApplication Receipt Date(s): August 11, 2022
-
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)
(RFA-DA-23-009)National Institute on Drug AbuseApplication Receipt Date(s): August 15, 2022
-
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional)
(RFA-DA-23-010)National Institute on Drug AbuseApplication Receipt Date(s): August 15, 2022
-
KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
(RFA-DK-21-033)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): December 3, 2024
-
NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)
(RFA-DK-22-004)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): June 21, 2022
-
National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)
(RFA-HD-23-011)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): July 28, 2022
-
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
(RFA-HL-23-007)National Heart, Lung, and Blood InstituteNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteApplication Receipt Date(s): October 12, 2022; October 12, 2023; October 12, 2024,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed)
(RFA-LM-22-001)National Library of MedicineApplication Receipt Date(s): May 31, 2022
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 13, 2025
For technical issues E-mail OER Webmaster